Chiauranib in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

NCT06492915 · clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
42
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Chipscreen Biosciences, Ltd.